Results of the LEVEL Study

Show Description +

The LEVEL Study assessed the efficacy of Macugen (pegaptanib sodium injection) as maintenance therapy in neovascular age-related macular degeneration (AMD). Thomas R. Friberg, MD, an investigator in the LEVEL study, explains the clinical findings and the impact on AMD treamtment.

Posted: 5/19/2010

Results of the LEVEL Study

The LEVEL Study assessed the efficacy of Macugen (pegaptanib sodium injection) as maintenance therapy in neovascular age-related macular degeneration (AMD). Thomas R. Friberg, MD, an investigator in the LEVEL study, explains the clinical findings and the impact on AMD treamtment.

Posted: 5/19/2010

Please log in to leave a comment.

More in Retina

How Useful is the Normative Database for Myopic Patients?

Fernando Gomez Goyeneche, MD

Diagnostic Pursuits Using Advanced Insights into Morphologic Changes in Chorioretinal Disease

Thomas Ach, MD, MSc, FEBO; Thomas Desmettre MD, PhD; Yoko Miura, MD, PhD; Rodrigo Abreu González, MD, PhD, FEBO